‘Experience has taught us that vaccines are able to eradicate infections from this planet.’ Illustration: James Melaugh/Guardian Design
10 Apr 2020 – As the daughter of an air force officer and a nurse, I am fascinated by defence systems. There is none more impressive than the human immune system, equipped as it is with a rich arsenal to defend against different types of pathogen. Viruses have evolved to trick, bypass and evade these defences. Our immune systems have, in turn, learned to recognise and deter these virus stealth tactics. In Covid-19, the enemy is a tiny piece of genetic material wearing a lipid coat and a protein crown.
So how is our immune system able to defend against viral infections, and how does this apply to Covid-19? The virus that causes Covid-19 is called severe acute respiratory syndrome coronavirus 2 (Sars-Cov-2), and was first detected in humans around five months ago. It is a coronavirus. “Corona”, in Latin, means crown. The virus is adorned with an outer layer of protein covered in spikes, like a crown. These spikes help the virus attach itself to target cells. The research community is fast learning about immunity to Covid-19, and we are also applying our knowledge of similar respiratory viruses to predict what to expect in this infection.
Think of a virus as a robot; it cannot reproduce so it needs a factory of materials – proteins, lipids and nucleotides – to build copies of itself. The coat allows the virus to attach itself to the target cell’s membrane. The virus then fuses with the cell and releases a shopping list of instructions on how to build and assemble new viruses. This shopping list, the virus genome, is written in nucleotides (RNA). The first job of a virus that enters our bodies is to invade target cells so that it can comfortably remove its coat and deploy its RNA.
Once inside, the virus commandeers the cell and borrows cellular machinery to build more viruses before immune cells detect the intruders and raise the alarm. Antibody proteins that are able to stick to the virus-spike proteins, and prevent attachment to the target cells, are called neutralising antibodies: generating them is often the goal of protective vaccination.
Our infected cells make the ultimate sacrifice and invite their own destruction by displaying distress signals for T-cells, which swiftly detect and kill them. T-cells are cytotoxic – powerful serial killers that can recognise peptide fragments of virus displayed on the infected cell surface. When they do, they release a payload of toxic enzymes that kill the infected cell in a “kiss of death”. This strategic martyrdom is organised by the immune system to deprive the virus of its replication factories and can lead to the reduction of viral load in the patient. It takes several days for antiviral T-cells to expand and antibodies to be generated. Here’s the silver lining: memory cells ensure that if we encounter the same virus again, we can react immediately with pre-existing defences. Sars-Cov-2 is new to humanity so we have no protective immunological memory. Vaccines prepared using harmless parts of the virus can help us build protective memory.
The virus’s enemy superpower is spreading. The virus achieves this through “shedding” from infected patients. Sars-Cov-2 is expert at hopping from person to person, and in some people, it achieves a stealthy existence with mild or no symptoms. Once many copies of the virus are made, it needs to jump to another host. It hitches a ride on droplets that can be coughed or sneezed to a distance of up to two metres. Droplets can survive on surfaces for several hours enabling pick–up by a new host, or they can be directly inhaled if another person is in close proximity. Studies are emerging into animal hosts – so far the virus has been detected in a few ferrets, cats, tigers and dogs. No animal deaths have yet been reported, and we don’t know if animals can transmit back to humans.
The age differential in fatalities for Covid-19 suggests, with some exceptions, that a healthy immune system is usually able to control infection. Meanwhile, an ageing or weakened immune system may struggle to deploy a protective arsenal. Importantly, Sars-Cov-2 cannot gain entry to our homes or bodies by itself – we have to let it in. This is why official advice has centred around cleaning our hands and avoiding touching our faces.
We know that a healthy immune system is usually able to eliminate infection in a couple of weeks. However, we have no understanding of the components of our immune arsenal that contribute to this feat: some vaccines work by creating potent neutralising antibodies; other vaccines generate powerful memory T-cells. Antiviral antibodies emerge as early as three to four days after virus detection, but are they protective against future reinfection? We believe that antibodies to other coronaviruses (Sars, Mers) last from one to three years. Because this is a new virus, we don’t yet know the answer to this question. Public Health England is recruiting 16,000 to 20,000 volunteers to monitor antibodies once a month for six to 12 months to confirm whether we can generate long-lasting antibody responses to Sars-Cov-2. Determining the quality of these antibodies will be important to understanding long-term protection.
What is our most potent immune weapon against Covid-19? Cytotoxic T-cells may play an important role. Immunologists and virologists are working together to discover the correlates of protection, to design vaccines that offer long-term defences against Covid-19. Years of investment in research means that we can use existing approaches to respond to this new threat, and early mobilisation of research funders, philanthropists and academics are diverting resources to bolster these efforts on an unprecedented scale. Experience has taught us that vaccines are able to eradicate infections from this planet (for instance, smallpox), and medicines against viruses that don’t embed their genetic material to our own (for example, hepatitis C) can also achieve this.
Our secret weapon is research. Scientists are working hard on understanding Covid-19, and collaboration is key to this effort. But until a vaccine or treatment is available, we ought to work hard to protect ourselves and our families: isolate and prevent transmission by using physical distancing, face masks and sensible hygiene. If we all do our part, this little virus holding the world to ransom won’t stand a chance.
_______________________________________________
Zania Stamataki is a senior lecturer and researcher in viral immunology at the University of Birmingham.
DISCLAIMER: The statements, views and opinions expressed in pieces republished here are solely those of the authors and do not necessarily represent those of TMS. In accordance with title 17 U.S.C. section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. TMS has no affiliation whatsoever with the originator of this article nor is TMS endorsed or sponsored by the originator. “GO TO ORIGINAL” links are provided as a convenience to our readers and allow for verification of authenticity. However, as originating pages are often updated by their originating host sites, the versions posted may not match the versions our readers view when clicking the “GO TO ORIGINAL” links. This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a ‘fair use’ of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material from this site for purposes of your own that go beyond ‘fair use’, you must obtain permission from the copyright owner.
One Response to “Here’s How Your Body Gains Immunity to Coronavirus”
Stamataki has forgotten the most important of all: how to make the immune system effective enough that the virus is conquered, thus avoiding getting very ill and even avoiding death. Four strategies have been proven to work to this end: Eat a low carb/high fat diet in order to keep the blood sugar level at a low normal level. Since glucose is needed by leucocytes, a low blood sugar will render part of the immune system inefficient. If blood glucose is too high, glucose molecules will outcompete vitamin C, which has an important role in helping leucocytes fighting virus and in producing complement, which attaches to infected cells and prevent virus replication. Ingestion of large doses of vitamin C and/or i.v. infusion (up to 100 g/d or more) will help kill ANY virus. This has been shown in clinical practice for about 80 years, pioneered by MD Frederick Klenner (1907-1984) and MD Robert Cathcart jr. III (1932-2007). The third defence for everyone living at high latitudes is getting enough vitamin D, another important part of the immune system, during the 6-7 months when the sun is too week to produce vitamin D in our bodies with its life-giving UV rays. The fourth is to add all other important components needed by our immune system, like zink, selenium, B vitamins, etc. Given the fact the up to 70% of the population in many countries is overweight, many suffering from diabetes and other symptoms of insulin resistance, the first strategy to avoid disease would be to cut down on all foods to which we have not been selected for during evolution – in particular sugar, cereal grains, soft drinks, sweets, cookies, etc. – and eat a variant of a stone age diet.
Stamataki has forgotten the most important of all: how to make the immune system effective enough that the virus is conquered, thus avoiding getting very ill and even avoiding death. Four strategies have been proven to work to this end: Eat a low carb/high fat diet in order to keep the blood sugar level at a low normal level. Since glucose is needed by leucocytes, a low blood sugar will render part of the immune system inefficient. If blood glucose is too high, glucose molecules will outcompete vitamin C, which has an important role in helping leucocytes fighting virus and in producing complement, which attaches to infected cells and prevent virus replication. Ingestion of large doses of vitamin C and/or i.v. infusion (up to 100 g/d or more) will help kill ANY virus. This has been shown in clinical practice for about 80 years, pioneered by MD Frederick Klenner (1907-1984) and MD Robert Cathcart jr. III (1932-2007). The third defence for everyone living at high latitudes is getting enough vitamin D, another important part of the immune system, during the 6-7 months when the sun is too week to produce vitamin D in our bodies with its life-giving UV rays. The fourth is to add all other important components needed by our immune system, like zink, selenium, B vitamins, etc. Given the fact the up to 70% of the population in many countries is overweight, many suffering from diabetes and other symptoms of insulin resistance, the first strategy to avoid disease would be to cut down on all foods to which we have not been selected for during evolution – in particular sugar, cereal grains, soft drinks, sweets, cookies, etc. – and eat a variant of a stone age diet.